Ann: Second Supplementary Scheme Booklet, page-20

Yes. A BOD that acts like this sends a very amateur, untrustworthy message to the world. I just can't trust them to deliver something that is so needed. There has not been a better set of circumstances globally to introduce Dx, yet, here we are. TK repeatedly refuses to let shareholders know what is going on, for example he told an interviewer a number of months back that Alodokter usage was looking strong (or words to that effect) yet that wasn't relayed to shareholders. We had to hear it on the interview.

Also, I have taken advantage of a pullback in another company to load up on their shares. Moving the risk to something that is undervalued yet being proven in it's market. It has been an interesting ride. I'm still prepared to get back in but not whilst this circus is playing out.